Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Atul Butte

Premium

SV Angel, a San Francisco-based investor, has tapped Atul Butte, a Stanford University School of Medicine professor and researcher, to serve as one of its advisors.

He'll help guide the company's plans to invest in informatics firms that develop and use software and IT infrastructure to analyze medical and molecular data to help diagnose and treat disease.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.